The abstract is read at the publisher; the summary is JClub's.
A human-specific SVA-F retrotransposon inserted into intron 32 of TAF1 is linked to reduced hyTAF1 expression and male mouse lethality within 2 months in neuronal-lineage humanized models.
- Why it matters: X-linked dystonia-parkinsonism is associated with retrotransposon insertions, but how a specific SVA insertion alters TAF1 transcriptional output and neuronal viability is unclear.
- What they did: The authors genomically rewrote a mouse Taf1 allele to match a 78-kb XDP patient-derived TAF1 allele, then used chromatin/transcriptome profiling and mESC assays, plus neuronal-lineage TAF1 humanization in mice.
- The result: Intronic SVAs were actively transcribed, forming barriers that downregulated TATA-box–enriched genes and triggered apoptosis; in mice this produced striatum-centered atrophy and lethality, while CRISPRa activation of hyTAF1 restored mESC viability.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.